Publications by authors named "T P Prindiville"

Objective: The human intestine harbors trillions of commensal microbes that live in homeostasis with the host immune system. Changes in the composition and complexity of gut microbial communities are seen in inflammatory bowel disease (IBD), indicating disruption in host-microbe interactions. Multiple factors including diet and inflammatory conditions alter the microbial complexity.

View Article and Find Full Text PDF

Background: Development of inflammatory bowel disease (IBD) involves the interplay of environmental and genetic factors with the host immune system. Mechanisms contributing to immune dysregulation in IBD are not fully defined. Development of novel therapeutic strategies is focused on controlling aberrant immune response in IBD.

View Article and Find Full Text PDF
Article Synopsis
  • Women exhibit higher immune activation and inflammatory gene expression in gut mucosal samples compared to men, particularly in CD4+ and CD8+ T cells.
  • The study analyzed blood and intestinal samples from 34 healthy individuals to examine sex differences in immune responses.
  • Findings suggest that baseline sex-related differences in immune activation might make women more susceptible to inflammation-related diseases.
View Article and Find Full Text PDF

Interruption of suppressive highly active antiretroviral therapy (HAART) in HIV-infected patients leads to increased HIV replication and viral rebound in peripheral blood. Effects of therapy interruption on gut-associated lymphoid tissue (GALT) have not been well investigated. We evaluated longitudinal changes in viral replication and emergence of viral variants in the context of T cell homeostasis and gene expression in GALT of three HIV-positive patients who initiated HAART during primary HIV infection but opted to interrupt therapy thereafter.

View Article and Find Full Text PDF

Background: 6-mercaptopurine (6-MP) is used for the induction and maintenance of remission of inflammatory bowel disease (IBD). 6-MP is converted into 6-methylmercaptopurine (6-MMP) or 6-thioguanine nucleotides (6-TGN) intracellularly. Treatment response in IBD patients correlates with 6-TGN levels.

View Article and Find Full Text PDF